Found: 18
Select item for more details and to access through your institution.
Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV, a randomized trial of the sodium‐glucose cotransporter‐2 inhibitor ertugliflozin
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 758, doi. 10.1111/dom.14923
- By:
- Publication type:
- Article
What have we learned about renal protection from the cardiovascular outcome trials and observational analyses with SGLT2 inhibitors?
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, p. 55, doi. 10.1111/dom.13965
- By:
- Publication type:
- Article
The Effect of Urine pH and Urinary Uric Acid Levels on the Development of Contrast Nephropathy.
- Published in:
- Kidney & Blood Pressure Research, 2020, v. 45, n. 1, p. 131, doi. 10.1159/000504547
- By:
- Publication type:
- Article
The effect of sex on humanin levels in healthy adults and patients with uncomplicated type 1 diabetes mellitus.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2015, v. 93, n. 4, p. 239, doi. 10.1139/cjpp-2014-0401
- By:
- Publication type:
- Article
Urinary ACE2 in healthy adults and patients with uncomplicated type 1 diabetes.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2014, v. 92, n. 8, p. 703, doi. 10.1139/cjpp-2014-0065
- By:
- Publication type:
- Article
Systemic hemodynamic function in humans with type 1 diabetes treated with protein kinase Cβ inhibition and renin-angiotensin system blockade: a pilot study.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2012, v. 90, n. 1, p. 113, doi. 10.1139/y11-106
- By:
- Publication type:
- Article
Virtual Pharmacy: An Integrated Collaborative Redesign Targeting Medication-Related Problems in Patients with Chronic Kidney Disease.
- Published in:
- American Journal of Nephrology, 2024, v. 55, n. 2, p. 206, doi. 10.1159/000535094
- By:
- Publication type:
- Article
Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial.
- Published in:
- American Journal of Nephrology, 2022, v. 53, n. 7, p. 516, doi. 10.1159/000524889
- By:
- Publication type:
- Article
Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The angiotensin II receptor type 2 polymorphism influences haemodynamic function and circulating RAS mediators in normotensive humans.
- Published in:
- Nephrology Dialysis Transplantation, 2010, v. 25, n. 12, p. 4093, doi. 10.1093/ndt/gfq564
- By:
- Publication type:
- Article
Point-of-Care Capillary Blood Ketone Measurements and the Prediction of Future Ketoacidosis Risk in Type 1 Diabetes.
- Published in:
- Diabetes Care, 2023, v. 46, n. 11, p. 1973, doi. 10.2337/dc23-0840
- By:
- Publication type:
- Article
Effects of Tirzepatide Versus Insulin Glargine on Cystatin C–Based Kidney Function: A SURPASS-4 Post Hoc Analysis.
- Published in:
- Diabetes Care, 2023, v. 46, n. 8, p. 1501, doi. 10.2337/dc23-0261
- By:
- Publication type:
- Article
The Effects of Sotagliflozin in Type 1 Diabetes on Clinical Markers Associated With Cardiorenal Protection: An Exploratory Analysis of inTandem3.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Changes in Cardiovascular Biomarkers Associated With the Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Ertugliflozin in Patients With Chronic Kidney Disease and Type 2 Diabetes.
- Published in:
- 2021
- By:
- Publication type:
- Letter
The Acute Effect of Clamped Hyperglycemia on the Urinary Excretion of Inflammatory Cytokines/Chemokines in Uncomplicated Type 1 Diabetes.
- Published in:
- Diabetes Care, 2011, v. 34, n. 1, p. 177, doi. 10.2337/dc10-1219
- By:
- Publication type:
- Article
Interactive Effects of Empagliflozin and Hyperglycemia on Urinary Amino Acids in Individuals With Type 1 Diabetes.
- Published in:
- Diabetes, 2024, v. 73, n. 3, p. 401, doi. 10.2337/db23-0694
- By:
- Publication type:
- Article
Erratum. Association Between Obesity and Chronic Kidney Disease: Multivariable Mendelian Randomization Analysis and Observational Data From a Bariatric Surgery Cohort. Diabetes 2023;72:496–510.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Association Between Obesity and Chronic Kidney Disease: Multivariable Mendelian Randomization Analysis and Observational Data From a Bariatric Surgery Cohort.
- Published in:
- Diabetes, 2023, v. 72, n. 4, p. 496, doi. 10.2337/db22-0696
- By:
- Publication type:
- Article